| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 05/02/2002 | EP1200560A1 Melanin-concentrating hormone receptor |
| 05/02/2002 | EP1200456A1 Antisense modulation of pten expression |
| 05/02/2002 | EP1200447A1 Oxazinocarbazoles for the treatment of cns diseases |
| 05/02/2002 | EP1200440A1 Quinuclidine derivatives for treatment of neurological disorders |
| 05/02/2002 | EP1200438A2 Method for making debromohymenialdisine and analogs thereof |
| 05/02/2002 | EP1200432A1 Amido spiropiperidines promote the release of growth hormone |
| 05/02/2002 | EP1200422A2 Pyrazole compositions useful as inhibitors of erk |
| 05/02/2002 | EP1200419A1 Aminothiazole derivatives and their use as crf receptor ligands |
| 05/02/2002 | EP1200415A1 Diamino-1,2,4-triazole-carboxylic acid derivatives as gsk-3 inhibitors |
| 05/02/2002 | EP1200396A1 Naphthylsulfonic acids and related compounds as glucose uptake agonists |
| 05/02/2002 | EP1200385A1 Crystals of the sodium salt of pravastatin |
| 05/02/2002 | EP1200117A2 Lipoprotein lipase (lpl) variant therapeutics |
| 05/02/2002 | EP1200111A1 Compositions for the treatment of the catabolic state of prolonged critical illness |
| 05/02/2002 | EP1200086A2 Methods for treating or preventing pain and anxiety |
| 05/02/2002 | EP1200085A1 Pharmaceutical and nutritional compositions containing essential fatty acids and homocysteine-lowering agents |
| 05/02/2002 | EP1200082A1 Preparations for reducing oxygen consumption during physical efforts |
| 05/02/2002 | EP1200076A1 Calcilytic compounds |
| 05/02/2002 | EP0941097B1 Use of mixtures of active substances for the production of hypocholesteremic agents |
| 05/02/2002 | EP0846118B1 Cyclic gmp-specific phosphodiesterase inhibitors |
| 05/02/2002 | EP0765336B1 Synthesis of conduritol epoxides and aziridines and methods of using such to synthesize higher disaccharides |
| 05/02/2002 | DE10049549A1 Inhibitor of the transcription factor IFR-1, useful for treating e.g. transplant rejection and autoimmune disease, reduces expression of CD40 |
| 05/02/2002 | CA2428907A1 Use of pericyte apoptosis inhibitors for treating and/or preventing diabetic retinopathy |
| 05/02/2002 | CA2427085A1 Transmembrane proteins |
| 05/02/2002 | CA2427024A1 Methods for screening compounds that modulate lipid metabolism |
| 05/02/2002 | CA2427005A1 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 05/02/2002 | CA2426895A1 Compounds comprising a phytosterol and/or phytostanol moiety and ascorbis acid and use thereof as weight regulating agents |
| 05/02/2002 | CA2426773A1 Beta-substituted beta-aminoethyl phosphonates |
| 05/02/2002 | CA2426736A1 Vegf peptides and their use for inhibiting angiogenesis |
| 05/02/2002 | CA2426672A1 Compositions and methods for diagnosis and treatment of cardiovascular disorders |
| 05/02/2002 | CA2426294A1 Nucleic acid generating the abca7 gene, molecules modulating its activity and therapeutic applications |
| 05/02/2002 | CA2426218A1 Compositions for improving lipid content in the blood |
| 05/02/2002 | CA2426007A1 A novel crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride |
| 05/02/2002 | CA2425288A1 Pyrrolidine modulators of ccr5 chemokine receptor activity |
| 05/02/2002 | CA2425283A1 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 05/02/2002 | CA2425280A1 Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 05/02/2002 | CA2422900A1 New composition and method for the treatment of dysglucaemia |
| 05/02/2002 | CA2420727A1 Triazole derivatives and pharmaceutical compositions comprising them |
| 05/01/2002 | CN1347414A Triazole compounds with dopamine-D3-receptor affinity |
| 05/01/2002 | CN1347408A Use of maduraphthalazine derivs. as inhibitors of pro-inflammatory cytokins |
| 05/01/2002 | CN1347328A Dry acid-chitosan complexes |
| 05/01/2002 | CN1347325A Novel amide derivs. as growth hormone secretagogues |
| 05/01/2002 | CN1347320A Use of cholesterol-lowering agent |
| 05/01/2002 | CN1347317A Remedies |
| 05/01/2002 | CN1347283A eNOS mutations useful for gene therapy and therapeutic screening |
| 05/01/2002 | CN1346888A Method for producing transgene non-human mammal |
| 05/01/2002 | CN1346680A Precursor gene of human insulin for treaitng diabetes by direct intramuscular injection and plasmid containing said gene |
| 05/01/2002 | CN1346672A Medicine for treating diabetes and its preparing process |
| 05/01/2002 | CN1346642A 降糖茶 Hypoglycemic tea |
| 05/01/2002 | CN1346635A Functional nutritive nucleic acid and polyose product and its preparing process |
| 05/01/2002 | CN1083885C Method for producing pravastatin precursor ML-236B |
| 05/01/2002 | CN1083840C 8-azabicyclo [3.2.1] oct-2-ene derivs., their preparation and use |
| 05/01/2002 | CN1083838C Novel imidazole derivs., method for preparing same, use as medicine, and pharmaceutical compositions contg. same |
| 05/01/2002 | CN1083833C Sulfur-substd. azetidinone compounds useful as hypocholesterolemic agents |
| 05/01/2002 | CN1083831C Novel tricyclic compounds and drug compositions contg. same |
| 04/30/2002 | US6380408 Non-calcemic, antiproliferative, transcriptionally active sulfur-containing analogs of 1α, 25-dihydroxy vitamin D3 |
| 04/30/2002 | US6380374 Isolated nucleic acid; culture product |
| 04/30/2002 | US6380257 Used as glucose-6-phosphate translocase inhibitors and can be used in therapy of diabetes mellitus |
| 04/30/2002 | US6380255 Treatment for dermal skin atrophy using thyroid hormone compounds or thyroid hormone-like compounds |
| 04/30/2002 | US6380251 Therapy of ocular hypertension which comprises administering cyclopentane heptan(ene)oic acid or its 2-thiocarbamoyloxy and 2-carbamoyloxy derivatives |
| 04/30/2002 | US6380250 Therapy of ocular hypertension which comprises administering cyclopentane heptan(ene)oic acid or its 2-thiocarbamoyloxy and 2-carbamoyloxy derivatives |
| 04/30/2002 | US6380244 Nutritional and therapeutic uses of 3-hydroxyalkanoate oligomers |
| 04/30/2002 | US6380238 Indoline derivatives as 5-HT2B and or 5-HTC receptor ligands |
| 04/30/2002 | US6380230 For therapy of dyskinesia, obesity, irritable bowel syndrome, diseases whose treatment requires stimulation of the cholecystokinin cck-a receptors |
| 04/30/2002 | US6380229 Useful for therapy and prophylaxis of hyperlipidemia and related complications |
| 04/30/2002 | US6380226 For therapy of migraine, cluster headache, chronic paroxysmal hemicrania or headache associated with a vascular disorder, depression, anxiety, an eating disorder, obesity, drug abuse, hypertension and emesis |
| 04/30/2002 | US6380224 For therapy of eating disorders, obesity, bulimia nervosa, diabetes, memory loss, epileptic seizures, migraine, sleep disturbances, pain, sexual/reproductive disorders, depression and anxiety |
| 04/30/2002 | US6380223 For therapy of diseases, such as obesity, diabetes, inflammation |
| 04/30/2002 | US6380218 For therapy of respiratory, allergic, and inflammatory disorders comprising asthma, chronic obstructive pulmonary disease, acute respiratory disease syndrome, pulmonary hypersensitivity, and allergic rhinitis in a mammal |
| 04/30/2002 | US6380211 For treating diabetes |
| 04/30/2002 | US6380200 Combination of aldose reductase inhibitors and selective serotonin reuptake inhibitors for the treatment of diabetic complications |
| 04/30/2002 | US6380197 For treating and preventing a plethora of diseases including diabetes |
| 04/30/2002 | US6380191 Arylthiazolidinedione and aryloxazolidinedione derivatives |
| 04/30/2002 | US6380184 For increased production of wool, milk, and meat by treating animals with therapeutically effective amount of compound |
| 04/30/2002 | US6380181 Synthetic catechol derivatives, method for production and use thereof |
| 04/30/2002 | US6380155 Use of vasopressin receptor antagonist for regulation of ACTH release |
| 04/30/2002 | US6379913 A polypeptide encoding an amino acid sequence; prevention and therapy for diabetes, inflammatory glomerulonephritis, ischemis renal failure, artherosclerosis, coronary vasoconstriction and ischemic heart disease |
| 04/30/2002 | US6379693 Trivalent chromium complex compound and milk product containing the same |
| 04/30/2002 | CA2233541C 8-azabicyclo[3.2.1]oct-2-ene derivatives, their preparation and use |
| 04/30/2002 | CA2172114C New thiophene compounds, process for preparing the same and pharmaceutical compositions containing them |
| 04/30/2002 | CA2059319C Formulations for oral administration, in particular to ruminants |
| 04/26/2002 | CA2324631A1 A substance or composition for the treatment of cancer |
| 04/25/2002 | WO2002033101A1 Chimeric cytoplasmic signalling molecules derived from cd137 |
| 04/25/2002 | WO2002033099A2 Human kinases |
| 04/25/2002 | WO2002033096A2 Regulation of human serine-threonine protein kinase |
| 04/25/2002 | WO2002033095A2 Regulation of human serine-threonine protein kinase |
| 04/25/2002 | WO2002033079A2 Human g-protein coupled receptor and uses thereof |
| 04/25/2002 | WO2002033063A1 Isocitrate dehydrogenase, gene thereof, and use of the same in the treatment of obesity, hyperlipidemia, and fatty liver in lipid biosynthesis |
| 04/25/2002 | WO2002032961A2 Novel polypeptides and nucleic acids encoding same |
| 04/25/2002 | WO2002032958A2 Polynucleotide and polypeptide sequences of human dendritic cell immunoreceptors |
| 04/25/2002 | WO2002032920A2 Modified nucleosides for treatment of viral infections and abnormal cellular proliferation |
| 04/25/2002 | WO2002032901A2 Bridged piperazine derivatives |
| 04/25/2002 | WO2002032900A2 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 04/25/2002 | WO2002032897A1 Alpha-aryl ethanolamines and their use as beta-3 adrenergic receptor agonists |
| 04/25/2002 | WO2002032896A1 Furazanyl-triazole derivates for the treatment of diseases |
| 04/25/2002 | WO2002032893A2 Piperidine compounds as anti-allergic |
| 04/25/2002 | WO2002032883A1 Novel 4-benzyloxyphenyl derivative and use thereof |
| 04/25/2002 | WO2002032874A2 Substituted heterocyclic compounds for treating multidrug resistance |
| 04/25/2002 | WO2002032872A1 Nitrogenous aromatic ring compounds |
| 04/25/2002 | WO2002032861A2 Orally active salts with tyrosine kinase activity |
| 04/25/2002 | WO2002032842A2 Compounds with high monoamine transporter affinity |